HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

FDA Commissioner Marty Makary to resign, capping turbulent tenure: report

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief but tumultuous tenure marked by mounting criticism from all sides, according to reports.

By FiercePharma · May 13, 2026 · via FiercePharma
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
Trump reportedly weighs ouster of FDA chief Marty Makary
PeopleBriefing
Reports say President Trump may remove FDA Commissioner Marty Makary following internal turnover and disputes …
May 9, 2026
BioNTech to scale down manufacturing, over 1,800 jobs on the line
PeopleEndpoints News ↗
BioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earni…
May 5, 2026
CBER chief Prasad steps aside, deputy takes the reins as search for successor continues
PeopleFierceBiotech ↗
Katherine Szarama, Ph.D., will take over as CBER director in an acting capacity while the search for a permane…
May 3, 2026